Clinical Trials Logo

Parotid Tumor clinical trials

View clinical trials related to Parotid Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT05401370 Not yet recruiting - Parotid Tumor Clinical Trials

Role of Methylene Blue in Parotid Surgery

Start date: June 2022
Phase: N/A
Study type: Interventional

usefulness of the methylene blue staining for identification of facial nerve in parotid gland surgery

NCT ID: NCT05152056 Completed - Parotid Tumor Clinical Trials

MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Parotid
Start date: November 15, 2021
Phase:
Study type: Observational

What value is given to MRI diffusion and perfusion sequences in the diagnosis of parotid tumors? Is a fine needle aspiration associated with MRI systematically necessary? The aim of the research is to study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases.

NCT ID: NCT04803032 Completed - Surgery Clinical Trials

Trident Landmark as a Safe and Easy Method for Facial Nerve Trunk Identification During Superficial Parotidectomy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The parotid has a close relationship with the extra temporal course of the facial nerve. The study aimed to evaluate the accuracy and safety of trident landmark during superficial parotidectomy in the identification of the facial nerve trunk.

NCT ID: NCT04613349 Recruiting - Parotid Tumor Clinical Trials

FArial NErf MRI in the Preoperative Assessment of PArotide Tumors

NEFAPA
Start date: January 13, 2021
Phase:
Study type: Observational

1. st visit: Inclusion, 3Tesla injected parotid MRI performed as part of routine care for characterization, to which two specific high resolution sequences will be added. Evaluation of the exact position of the parotid tumor relative to the trunk of the facial nerve and its first branches, classification into two categories: on contact (≤ 5 mm) or at a distance (> 5 mm). 2. nd visit: Surgical intervention of the parotid tumor. The surgeon will specify the same data as that collected by the radiologists after the MRI. 3. rd visit: Post-operative consultation in the week following the intervention. The surgeon will look for the occurrence of post-operative facial paralysis.

NCT ID: NCT04104802 Withdrawn - Parotid Tumor Clinical Trials

Study of the Facial Nerve in MRI 3T in the Preoperative Assessment of Parotid Tumors

FACPAR
Start date: October 2019
Phase:
Study type: Observational

Preoperative evaluation of the precise localization of the intrapartotic facial nerve is essential for the ENT surgeon to assess the risk of nerve damage during parotid tumor excision, and inform the patient of the risk of post-paralyzed facial nerve palsy. procedure

NCT ID: NCT04028479 Recruiting - Breast Cancer Clinical Trials

The Registry of Oncology Outcomes Associated With Testing and Treatment

ROOT
Start date: May 5, 2021
Phase:
Study type: Observational [Patient Registry]

This study is to collect and validate regulatory-grade real-world data (RWD) in oncology using the novel, Master Observational Trial construct. This data can be then used in real-world evidence (RWE) generation. It will also create reusable infrastructure to allow creation or affiliation with many additional RWD/RWE efforts both prospective and retrospective in nature.

NCT ID: NCT03950323 Recruiting - Parotid Tumor Clinical Trials

Intra-parotid Facial Nerve Tractography

R-PO19053
Start date: June 24, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate concordance between the facial nerve's path in the parotid evaluated by radiologist in preoperatively and the facial nerve's path in the parotid evaluated by surgeon in peroperatively.

NCT ID: NCT01414790 Completed - Parotid Tumor Clinical Trials

The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The aim of the study was to explore whether human acellular dermal matrix (ADM) implantation could prevent infraauricular depressed deformities and Frey's syndrome following total parotidectomy.